Pharmafile Logo

doc2doc

- PMLiVE

Amgen buys total filgrastim rights from Roche

Wrests control of white blood cell stimulator franchise

Novartis building

NICE backs Novartis/ ThromboGenics’ eye drug

Recommends Jetrea for NHS use in England and Wales to treat the rare disease vitreomacular traction

- PMLiVE

EMA defends position on patient-level data

Regulator claims pharma industry fears over transparency are unfounded

- PMLiVE

Walgreens: UK homecare sector could learn from the US

Pharmacy chain calls on UK to focus more on measuring the benefits of homecare

- PMLiVE

Michael Wyzga OncoMed board

He brings financial experience from Genzyme

- PMLiVE

Synergy Vision expands UK and Ireland team

Sharon Hurley has experience at Pfizer

- PMLiVE

Pharmacy sales partners

How do you choose the right contract sales and marketing partner for your needs?

Google Glass passes clinical ‘proof of concept’

Philips-Accenture project trials patient data delivery via smart-glasses

- PMLiVE

Ariad tanks as Iclusig trial is halted on safety grounds

Shares fall after leukaemia patients develop blood clots

- PMLiVE

FDA sets up rare disease research fund

Will invest $14m across 15 orphan drug projects

- PMLiVE

AstraZeneca moves MEK inhibitor selumetinib into phase III

Begins late-stage trials of its targeted lung cancer drug

New chair of the British Pharmacopoeia Commission

UCL's Kevin Taylor to lead body to oversee pharmaceutical standards

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links